April 26, 2017
Recommended Topic Related To:

Anzemet Tablets

"The U.S. Food and Drug Administration today expanded the approved uses of Abraxane (paclitaxel protein-bound particles for injectable suspension, albumin-bound) to treat patients with late-stage (metastatic) pancreatic cancer.



Anzemet Tablets

How Supplied


ANZEMET Tablets are indicated for the prevention of nausea and vomiting associated with moderately emetogenic cancer chemotherapy, including initial and repeat courses in adults and children 2 years and older.


The recommended doses of ANZEMET Tablets should not be exceeded.


The recommended oral dosage of ANZEMET (dolasetron mesylate) is 100 mg given within one hour before chemotherapy.

Pediatric Patients

The recommended oral dosage in pediatric patients 2 to 16 years of age is 1.8 mg/kg given within one hour before chemotherapy, up to a maximum of 100 mg. Safety and effectiveness in pediatric patients under 2 years of age have not been established.

In children for whom the 100 mg tablet is not appropriate based on their weight or ability to swallow tablets, the ANZEMET Injection solution may be mixed into apple or apple-grape juice for oral dosing in pediatric patients. The diluted product may be kept up to 2 hours at room temperature before use. However, ANZEMET Injection solution when administered intravenously is contraindicated in adult and pediatric patients for the prevention of nausea and vomiting associated with initial and repeat courses of emetogenic cancer chemotherapy due to dose dependent QT prolongation.

Use in the Elderly, Renal Failure Patients, or Hepatically Impaired Patients

No dosage adjustment is recommended, however; ECG monitoring is recommended for elderly and renally impaired patients (see WARNINGS and CLINICAL PHARMACOLOGY, Pharmacokinetics in Humans).


ANZEMET® Tablets (dolasetron mesylate)

Strength Quantity NDC Number Description
50 mg 5 ct Bottle 0088-1202-05 Light pink, film coated, round tablet imprinted with “A” on one side and “50”on the other.
10 ct Unit Dose Pack 0088-1202-43
100 mg 5 ct Bottle 0088-1203-05 Pink, film coated, elongated oval tablet imprinted with “100” on one side and “ANZEMET” on the other.
10 ct Unit Dose 0088-1203-43
5 ct Blister Pack 0088-1203-29

Store at controlled room temperature 20-25°C (68-77°F). Protect from light.

Manufactured by: Patheon Pharmaceuticals Inc. Cincinnati, OH 45237. Manufactured for: sanofi-aventis U.S. LLC Bridgewater, NJ 08807. A Sanofi Company. Revised: September of 2013

This monograph has been modified to include the generic and brand name in many instances.

Last reviewed on RxList: 11/16/2016

How Supplied

Anzemet Tablets - User Reviews

Anzemet Tablets User Reviews

Now you can gain knowledge and insight about a drug treatment with Patient Discussions.

Here is a collection of user reviews for the medication Anzemet Tablets sorted by most helpful. Patient Discussions FAQs

Report Problems to the Food and Drug Administration


You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.


Get the latest treatment options.

Related Drugs
Health Resources
Related Supplements
Use Pill Finder Find it Now See Interactions

Pill Identifier on RxList

  • quick, easy,
    pill identification

Find a Local Pharmacy

  • including 24 hour, pharmacies

Interaction Checker

  • Check potential drug interactions
Search the Medical Dictionary for Health Definitions & Medical Abbreviations